✦ LIBER ✦

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

✍ Scribed by Michael D. Ezekowitz; Stuart Connolly; Amit Parekh; Paul A. Reilly; Jeanne Varrone; Susan Wang; Jonas Oldgren; Ellison Themeles; Lars Wallentin; Salim Yusuf

Book ID: 116191705
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 236 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2009.02.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review of the Randomized Evaluation of L

Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran

✍ Christopher Ingelmo; Oussama Wazni 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 82 KB

Periprocedural Bleeding and Thromboembol

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial

✍ Healey, J. S.; Eikelboom, J.; Douketis, J.; Wallentin, L.; Oldgren, J.; Yang, S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 965 KB

Efficacy and Safety of Dabigatran Compar

Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation: Results From the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Study

✍ Greg Flaker; Michael Ezekowitz; Salim Yusuf; Lars Wallentin; Herbert Noack; Mart 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 449 KB

Periprocedural Bleeding and Thromboembol

Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared with Warfarin: Results from the Randomized Evaluation of Long-term Anticoagulation Therapy Randomized Trial: Healey JS, Eikelboom J, Douketis J, et al. Circulation 2012;126:343–8.

✍ Jordan Ryan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Evaluation of the novel factor Xa inhibi

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

✍ Christian T. Ruff; Robert P. Giugliano; Elliott M. Antman; Sharon E. Crugnale; T 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 419 KB